.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Citi
Johnson and Johnson
Accenture
Covington
Daiichi Sankyo
UBS
Fish and Richardson
Chinese Patent Office
Express Scripts

Generated: June 24, 2017

DrugPatentWatch Database Preview

DOPAR Drug Profile

« Back to Dashboard

Which patents cover Dopar, and what generic Dopar alternatives are available?

Dopar is a drug marketed by Shire and is included in one NDA.

The generic ingredient in DOPAR is levodopa. There are sixteen drug master file entries for this compound. Additional details are available on the levodopa profile page.

Summary for Tradename: DOPAR

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list67
Patent Applications: see list7,990
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOPAR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire
DOPAR
levodopa
CAPSULE;ORAL016913-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Shire
DOPAR
levodopa
TABLET;ORAL016913-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Shire
DOPAR
levodopa
CAPSULE;ORAL016913-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Shire
DOPAR
levodopa
CAPSULE;ORAL016913-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Shire
DOPAR
levodopa
TABLET;ORAL016913-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Novartis
Colorcon
Julphar
UBS
Teva
Moodys
Chubb
Chinese Patent Office
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot